The abstract submission system is now closed.
View the abstracts in the online programme
Abstract submission deadlines
Deadline |
Date and time |
|---|---|
Regular abstracts |
10 May 2023, 21:00hrs CEST |
Late-breaking abstracts |
14 September 2023, 21:00hrs CEST A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on 10 May 2023. |
Outcome notifications
Outcome notifications are expected to be made available to first authors and submitters between 19 and 21 July 2023.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by end September.
Information for presenters
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website in early August 2023, in the section “Information for Presenters”.
Abstract submission categories
Basic science |
NSCLC, metastatic |
Biliary tract cancer, incl. cholangiocarcinoma |
Oesophagogastric cancer |
Biomarkers (agnostic) |
Palliative care |
Breast cancer, early stage |
Pancreatic cancer |
Breast cancer, locally advanced |
Policy and preventive strategies |
Breast cancer, metastatic |
Prostate cancer |
CNS tumours |
Psycho-oncology |
Colorectal cancer |
Renal cancer |
Developmental therapeutics |
Sarcoma |
Endocrine tumours |
SCLC |
Germ cell (testicular) cancer and penile cancer |
Supportive care |
Gynaecological cancers |
Thoracic malignancies, other |
Haematological malignancies |
Thyroid cancer |
Head and neck cancer, excluding thyroid |
Translational research (agnostic) |
Hepatocellular carcinoma (HCC) |
Tumour biology and pathology |
Investigational immunotherapy |
Urothelial cancer |
Melanoma and other skin tumours |
*Cancer nursing: eHealth and digital innovations |
Miscellaneous |
*Cancer nursing: Health promotion, prevention and screening |
NETs and endocrine tumours |
*Cancer nursing: Supportive care |
Neuroendocrine tumours |
*Cancer nursing: Symptom management |
New diagnostic tools |
*Cancer nursing: Palliative and end-of-life care |
NSCLC, early stage |
*Cancer nursing: Workforce and educational issues in cancer nursing |
NSCLC, locally advanced |
Late-breaking abstracts (LBA)
Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.
The final late-breaking abstract deadline of 14 September 2023 is under no circumstances to be considered as an extension of the general submission deadline.
Trial in progress abstracts (TiP)
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Congress 2023.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Presentation of accepted abstracts
The ESMO Congress 2023 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Presidential Symposium - Oral presentations of cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
- Proffered Paper – Oral presentations of original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentation of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
All accepted abstracts will be published in the ESMO Congress 2023 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.
Publication schedule of accepted abstracts
Details regarding the publication of accepted abstracts are available here.
ESMO Merit Travel Grants
A limited number of Merit Travel Grants to ESMO Congress 2023 are available, upon application, to first authors under the age of 40 (forty) who submit abstracts considered deserving of recognition. Selection will be made by the ESMO Congress 2023 Scientific Committee on a competitive basis from among the accepted abstracts.
EONS Novice Research Dissemination Award (NRDA)
The award is intended to give cancer nurses, who are relatively new to research, an opportunity to present their research at an international conference. Therefore, it is only open to cancer nurses who have not yet presented their research outside their own country.